Supporting information Spectomycin B1 as a novel SUMOylation ...

Report 5 Downloads 13 Views
Supporting information

Spectomycin B1 as a novel SUMOylation inhibitor that directly binds to SUMO E2

Mikako Hirohama, Ashutosh Kumar, Isao Fukuda, Seiji Matsuoka,Yasuhiro Igarashi, Hisato Saitoh, Motoki Takagi, Kazuo Shin-ya, Kaori Honda, Yasumitsu Kondoh, Tamio Saito, Yoichi Nakao, Hiroyuki Osada, Kam Y. J. Zhang, Minoru Yoshida, and Akihiro Ito* * Co-correspondence should be addressed to Akihiro Ito, E-mail: [email protected]

Table of contents Supplemental Table S1 Supplemental Figure S1 Supplemental Figure S2 Supplemental Figure S3 Supplemental Method

Supplemental Table S1. Oligonucleotides sequences used for RT-PCR Oligonucleotides

Sequence

pS2 sense

5’-CCCCTGGTGCTTCTATCCTAA-3’

pS2 antisense

5’-GATCCCTGCAGAAGTGTCTAAAA-3’

Ubc9 sense

5’-GGCACGATGAACCTCATGAA-3’

Ubc9 antisense

5’-TCCCACGGAGTCCCTTTCT-3’

Uba2 sense

5’-TCAAGAAGTATCTCCTGACAGAGC-3’

Uba2 antisense

5’-TGCTCTAGCTCTGGCTTCG-3’

β-actin sense

5’-ATGAAGATCAAGATCATTGCTCCTC-3’

β-actin antisense

5’-ACATCTGCTGGAAGGTGGACA-3’

a GFP-SUMO-1GG

GFP-SUMO-1G

Hoechst

Hoechst

b Digitonin

Recombinant E1, E2, GFP-SUMO-1, ATP

Sample

Supplemental Figure S1. System of screening for SUMOylation inhibitors. (a) In situ SUMOylation assay. In situ SUMOylation assay was performed as described in the Supplemental Method. GFP-SUMO-1GG but not GFP-SUMO-1G, defective mutant for SUMO conjugation activity, accumulated around the nuclear rim, indicating that the GFP signal at nuclear rim is attributed to SUMO conjugation activity in semi-intact cells. (b) Schematic model of the in situ cell-based screening system.

Supplemental Figure S2. Dose dependent inhibition of in vitro SUMOylation by chaetochromin A (a) and viomellein (b). The error bars show the standard deviations from three independent assays.

17

UbcH2A (Rad6)

SMB - +

UbcH3 (Cdc34)

*

*

ATP (-)

ATP (-)

DTT (+)

ATP (-)

DTT (+)

SMB - +

SMB - +

30

*

17

DTT (+)

17

UbcH2

17

25

17

UbcH1 (E2-25K)

SMB - +

30

*

DTT (+)

17

ATP (-)

ATP (-)

25

25

*

SMB - +

DTT (+)

ATP (-)

30

25

SMB - +

DTT (+)

30

SMB - +

DTT (+)

ATP (-)

DTT (+)

ATP (-)

SMB - +

25

17 17

25

SMB - +

25

*

* 17 17

17

UbcH7

17

UbcH8

UbcH10

UbcH13

Supplemental Figure S3. Effects of spectomycin B1 and DTT on thioester-bond formation between various ubiquitin E2s and biotinylated ubiquitin. The asterisk represents a non-specific band.

DTT (+)

ATP (-)

SMB - +

UbcH6 DTT (+)

ATP (-)

SMB - +

DTT (+)

ATP (-)

SMB - +

UbcH5c

UbcH5b

DTT (+)

ATP (-)

UbcH5a

Supplemental Method

In situ SUMOylation Assay HeLa cells were grown on a 96-well plate, briefly rinsed with cold TRB buffer (20 mM HEPES [pH 7.3], 110 mM KOAc, 2 mM MgCl2, 1 mM EGTA, 2 mM DTT) and permeabilized with TRB buffer containing 50 µg/ml digitonin (Calbiochem, Darmstadt, Germany) for 5 min on ice. After the cells were rinsed twice with ice-cold TRB buffer, 100 µl of assay solution containing 0.2 µg of GST-Aos1/Uba2 (E1), 0.2 µg of His-tagged Ubc9 (E2), 2 µg of GFP-SUMO, and ATP was added and incubated for 15 min at 30°C. The cells were washed with pre-warmed TRB buffer for 5 min at 30°C, followed by fixation with 3.7% formaldehyde in PBS for 15 min at room temperature. The cells were rinsed three times with PBS for 5 min, and then treated with 1 mg/ml Hoechst 33342 (Invitrogen) for 5 min. GFP signal around the nuclear rim was observed using a DeltaVision fluorescent microscope (GE Healthcare).